Multimodality Treatment of Pleural Mesothelioma

David D. Shersher; Michael J. Liptay

doi:10.1016/j.soc.2012.12.004

Multimodality Treatment of Pleural Mesothelioma

David D. Shersher
, Michael J. Liptay

Research output: Contribution to journal › Review article › peer-review

16 Scopus citations

Abstract

Although the treatment of malignant pleural mesothelioma has been refined during the past two decades, overall survival from this rather uncommon disease is still extremely poor. Here we review the current multimodal diagnostic and treatment options for patients with mesothelioma and discuss promising new experimental concepts in this disease.

Original language	English (US)
Pages (from-to)	345-355
Number of pages	11
Journal	Surgical Oncology Clinics of North America
Volume	22
Issue number	2
DOIs	https://doi.org/10.1016/j.soc.2012.12.004
State	Published - Apr 2013
Externally published	Yes

All Science Journal Classification (ASJC) codes

Surgery
Oncology

Access to Document

10.1016/j.soc.2012.12.004

Cite this

@article{84c95dbf985d42ac8ed5ad9db89773bf,

title = "Multimodality Treatment of Pleural Mesothelioma",

abstract = "Although the treatment of malignant pleural mesothelioma has been refined during the past two decades, overall survival from this rather uncommon disease is still extremely poor. Here we review the current multimodal diagnostic and treatment options for patients with mesothelioma and discuss promising new experimental concepts in this disease.",

author = "Shersher, \{David D.\} and Liptay, \{Michael J.\}",

year = "2013",

month = apr,

doi = "10.1016/j.soc.2012.12.004",

language = "English (US)",

volume = "22",

pages = "345--355",

journal = "Surgical Oncology Clinics of North America",

issn = "1055-3207",

publisher = "W.B. Saunders",

number = "2",

}

TY - JOUR

T1 - Multimodality Treatment of Pleural Mesothelioma

AU - Shersher, David D.

AU - Liptay, Michael J.

PY - 2013/4

Y1 - 2013/4

N2 - Although the treatment of malignant pleural mesothelioma has been refined during the past two decades, overall survival from this rather uncommon disease is still extremely poor. Here we review the current multimodal diagnostic and treatment options for patients with mesothelioma and discuss promising new experimental concepts in this disease.

AB - Although the treatment of malignant pleural mesothelioma has been refined during the past two decades, overall survival from this rather uncommon disease is still extremely poor. Here we review the current multimodal diagnostic and treatment options for patients with mesothelioma and discuss promising new experimental concepts in this disease.

UR - https://www.scopus.com/pages/publications/84875495635

UR - https://www.scopus.com/pages/publications/84875495635#tab=citedBy

U2 - 10.1016/j.soc.2012.12.004

DO - 10.1016/j.soc.2012.12.004

M3 - Review article

C2 - 23453339

AN - SCOPUS:84875495635

SN - 1055-3207

VL - 22

SP - 345

EP - 355

JO - Surgical Oncology Clinics of North America

JF - Surgical Oncology Clinics of North America

IS - 2

ER -

Multimodality Treatment of Pleural Mesothelioma

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this